• February 21, 2019
• 0

Novo Nordisk has received U.S. FDA approval for Esperoct (turoctocog alfa peg, N8-GP) for the treatment of children and adults with haemophilia A. Today's decision permits physicians to prescribe the drug for...

• February 11, 2019
• 0

The U.S. FDA are set to debate the viability of Johnson & Johnson's esketamine spray for major depression - a medication related to 'party drug' ketamine. Votes from the FDA's advisory committee...

• February 7, 2019
• 0

The U.S. FDA has granted Orphan Drug Designation (ODD) to Fasenra (benralizumab) for the treatment of hypereosinophilic syndrome.  The designation comes on the back of data from a phase II trial conducted...

• February 5, 2019
• 0

Roche is aiming to hasten use of its breast cancer drug Kadcyla with the submission to the FDA under the Real-Time Oncology Review and Assessment Aid programme. Kadcyla (trastuzumab emtansine)...